Table 5.
Cytokine and hs-CRP levels in the elderly patients with the proximal, middle, and distal LAD reocclusions.
| CON n = 69 | Dist LAD reocclusions n = 55 | Mid LAD reocclusions n = 49 | Prox LAD reocclusions n = 35 | Prox+Mid LAD reocclusions n = 29 | |
|---|---|---|---|---|---|
| IL-1 β (pg/mL) | 51.0 ± 8.2 | 69.0 ± 8.9∗ | 77.3 ± 10.5∗∗ | 109.8 ± 23.1∗∗∗ | 137.2 ± 27.4∗∗∗∗ |
| IL-6 (pg/mL) | 81.2 ± 20.4 | 93.4 ± 29.0∗ | 131.8 ± 42.3∗∗ | 147.9 ± 49.2∗∗∗ | 160.5 ± 57.3∗∗∗∗ |
| IL-8 (pg/mL) | 4.0 ± 0.9 | 6.1 ± 1.1∗ | 8.0 ± 3.2∗∗ | 13.5 ± 5.0∗∗∗ | 17.0 ± 7.5∗∗∗∗ |
| TNF-α (ng/L) | 60.3 ± 13.5 | 72.0 ± 14.7∗ | 90.6 ± 16.0∗∗ | 118.4 ± 18.2∗∗∗ | 125.0 ± 23.1∗∗∗∗ |
| IL-10 (pg/mL) | 19.1 ± 10.3 | 14.1 ± 9.0∗ | 9.5 ± 7.2∗∗ | 5.0 ± 3.2∗∗∗ | 2.9 ± 1.1∗∗∗∗ |
| IL-17 (pg/mL) | 15.3 ± 5.6 | 10.1 ± 5.0∗ | 6.9 ± 3.0∗∗ | 3.6 ± 3.7∗∗∗ | 1.8 ± 0.9∗∗∗∗ |
| IL-13 (pg/mL) | 410.1 ± 85.0 | 381.6 ± 77.4∗ | 311.2 ± 65.7∗∗ | 285.0 ± 43.1∗∗∗ | 199.7 ± 20.8∗∗∗∗ |
| IL-37 (pg/mL) | 124.0 ± 15.3 | 109.4 ± 13.0∗ | 97.3 ± 11.4∗∗ | 81.9 ± 9.7∗∗∗ | 59.8 ± 6.9∗∗∗∗ |
| hs-CRP (mg/L) | 3.2 ± 0.7 | 5.3 ± 1.0∗ | 7.5 ± 1.5∗∗ | 10.7 ± 2.0∗∗∗ | 12.5 ± 2.6∗∗∗∗ |
Student's t-test: ∗P < 0.001 (CON group/Dist LAD reocclusion group). ∗∗P < 0.001 (Dist LAD reocclusion group/Mid LAD reocclusion group). ∗∗∗P < 0.001 (Mid LAD reocclusion group/Prox LAD reocclusion group). ∗∗∗∗P < 0.001 (Prox LAD reocclusion group/Prox+Mid LAD reocclusion group). Group comparisons (CON/Dist LAD reocclusion group/Mid LAD reocclusion group/Prox LAD reocclusion group/Prox+Mid LAD reocclusion group) were made using ANOVA, P < 0.001.